c-Myc tag Peptide: Atomic Benchmarks for Immunoassay Precision

Executive Summary: The c-Myc tag Peptide (A6003) is a sequence-defined synthetic peptide corresponding to amino acids 410–419 of human c-Myc, designed for competitive displacement of c-Myc-tagged fusion proteins in immunoassays (APExBIO). This reagent provides high specificity for anti-c-Myc antibody binding inhibition, facilitating robust analysis of transcription factor regulation and proto-oncogene c-Myc function in cancer biology (c-Myc tag Peptide: Precision Displacement and Transcripti...). The product is highly soluble in DMSO (≥60.17 mg/mL) and water (≥15.7 mg/mL, with sonication), but insoluble in ethanol. Proper storage at –20°C ensures stability for research use. Its atomic mechanism enables reliable benchmarking in advanced immunoassays (Wu et al., 2021).

Biological Rationale

The c-Myc protein is a pivotal transcription factor encoded by the MYC proto-oncogene. It orchestrates gene expression programs that regulate cell proliferation, growth, apoptosis, and differentiation (Wu et al., 2021). c-Myc activation results in upregulation of cyclins and ribosomal components and downregulation of cell cycle inhibitors (such as p21) and anti-apoptotic factors (such as Bcl-2). Dysregulation of c-Myc is frequently implicated in oncogenesis and is a hallmark of many cancers. In laboratory research, the c-Myc tag (EQKLISEEDL) is widely used for protein labeling, enabling detection and purification in immunoassays. Synthetic c-Myc tag peptides serve as competitive inhibitors in these systems, allowing for displacement of c-Myc-tagged proteins bound to specific antibodies and facilitating mechanistic studies of dynamic protein interactions and transcription factor control (Unlocking Mechanistic Precision...).

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide is a synthetic decapeptide (sequence: EQKLISEEDL) that mimics the C-terminal epitope (residues 410–419) of human c-Myc protein. In immunoassays, it competitively binds to anti-c-Myc antibodies, thereby displacing c-Myc-tagged fusion proteins from antibody complexes. This mechanism enables highly specific inhibition of anti-c-Myc antibody binding. The peptide is typically used in molar excess compared to tagged proteins to achieve efficient displacement. Its solubility profile (≥60.17 mg/mL in DMSO; ≥15.7 mg/mL in water with sonication) ensures compatibility with a range of assay conditions (APExBIO). This atomic displacement mechanism is essential for troubleshooting, specificity controls, and quantitative studies in signal transduction and transcription factor research (c-Myc tag Peptide: Precision Reagent for Immunoassays and...), extending beyond the scope of previous reviews by detailing sequence-activity relationships.

Evidence & Benchmarks

• The c-Myc tag Peptide (A6003) enables specific, reversible displacement of c-Myc-tagged fusion proteins in immunoassays, supporting robust detection and quantification workflows (APExBIO).
• The product is insoluble in ethanol but achieves ≥60.17 mg/mL solubility in DMSO and ≥15.7 mg/mL in water after ultrasonic treatment, ensuring high-concentration compatibility in diverse protocols (APExBIO).
• c-Myc-driven gene amplification is a central pathway in cancer biology, with c-Myc tag peptides playing a critical role in dissecting these molecular mechanisms (Wu et al., 2021).
• The peptide's atomic displacement mechanism has been benchmarked as a gold standard for immunoassay specificity and troubleshooting, as detailed in recent technical reviews (c-Myc tag Peptide: Atomic Benchmarks for Immunoassay Prec...).
• Emerging evidence links the use of competitive tag peptides to improved control of transcription factor studies, including those involving autophagy-mediated regulation, as discussed in supplementary literature (Unlocking Mechanistic Precision...).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is primarily intended for use in competitive immunoassays, immunoprecipitation, and antibody specificity controls. It is not approved for diagnostic or therapeutic applications. When integrated into research workflows, the peptide enables reversible displacement of tagged proteins and fine control over antibody-driven detection systems. Compared to full-length c-Myc or alternative tags (e.g., FLAG, HA), the c-Myc tag Peptide offers sequence-defined specificity and minimal cross-reactivity. Recent literature extends these applications to mechanistic studies of transcription factor regulation and autophagy-linked gene expression (Wu et al., 2021). This article updates prior summaries (c-Myc tag Peptide: Precision Displacement and Transcripti...) by including detailed solubility and storage parameters validated in recent batch testing.

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide is not suitable for in vivo studies or therapeutic interventions; it is strictly for in vitro research use only.
• Solubility in ethanol is negligible; DMSO or water with sonication must be used for stock preparation (APExBIO).
• Prolonged storage of aqueous solutions leads to degradation; always store desiccated at –20°C and prepare fresh solutions for each experiment.
• Use of sub-stoichiometric concentrations relative to antibody or tagged protein can result in incomplete displacement and false-negative controls.
• The peptide does not inherently modulate c-Myc-driven transcription in cells; its function is limited to competitive binding in immunoassays.

Workflow Integration & Parameters

For optimal immunoassay performance, prepare a fresh stock solution of c-Myc tag Peptide in DMSO (preferably at ≥10 mM) or in water (≥2 mM with sonication). Add the peptide to samples containing c-Myc-tagged proteins in a 10–100x molar excess, incubate at room temperature for 10–30 minutes, and proceed with standard immunoprecipitation or ELISA protocols. Store lyophilized peptide desiccated at –20°C. Avoid repeated freeze-thaw cycles. The peptide is compatible with most buffer systems (pH 6–8) and does not interfere with downstream Western blot or mass spectrometry analyses. For advanced troubleshooting and best practices, see c-Myc tag Peptide: Precision Reagent for Immunoassays and..., which this article extends by providing atomic-level solubility and storage data for the A6003 kit.

Conclusion & Outlook

The c-Myc tag Peptide (APExBIO, A6003) is a gold-standard reagent for competitive displacement in immunoassays, enabling high-precision interrogation of transcription factor regulation and proto-oncogene function in cancer research. Its validated solubility and stability parameters ensure reproducibility and robustness in diverse workflows. Ongoing research continues to expand its applications in signal transduction and autophagy-driven transcription factor studies (Wu et al., 2021). For ordering and full technical details, visit the official product page.